Why is Aarey Drugs falling/rising?
As of 24-Sep, Aarey Drugs & Pharmaceuticals Ltd is currently priced at Rs 78.60, having risen 1.28% recently, with strong performance indicators including a 20.96% increase over the last month. Despite a significant drop in investor participation, the stock has outperformed the Sensex year-to-date, suggesting positive investor sentiment.
As of 24-Sep, Aarey Drugs & Pharmaceuticals Ltd is experiencing a price increase, with its current price at Rs 78.60, reflecting a rise of 0.99 or 1.28%. The stock has shown strong performance recently, with a 9.64% increase over the past week and a notable 20.96% rise over the last month. It is currently trading close to its 52-week high, just 4.29% away from Rs 81.97. Additionally, Aarey Drugs is outperforming its sector by 1.47% today and is trading above all its moving averages, indicating a positive trend. However, there has been a significant drop in investor participation, with delivery volume falling by 67% compared to the 5-day average, which may raise concerns about sustainability in the stock's upward movement.Broader market context shows that while Aarey Drugs has performed well, the benchmark Sensex has declined by 1.18% over the past week, highlighting the stock's relative strength in a challenging market environment. Year-to-date, Aarey Drugs has outperformed the Sensex significantly, with a return of 38.60% compared to the benchmark's 4.58%. This strong performance amidst a broader market downturn suggests that investor sentiment towards Aarey Drugs remains positive, despite the recent decline in trading volume.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
